Technology Bundle ID: TAB-2602

CDC Mosquito Trap for Control and Surveillance of Mosquitoes Including Carriers of Zika & Other Viruses

Request More Info
Licensing Contact:
Co-Inventors: 
Andrew Mackay (CDC), Manuel Amador (CDC)
Therapeutic Area: 
Infectious Disease
Development Status: 
  • Prototype
  • In vitro data available
Institute or Center: 
CDC

Mosquitoes are responsible for spreading many viruses that can make people sick, including dengue, Zika, chikungunya, yellow fever, and more. The Centers for Disease Control and Prevention's (CDC's) new autocidal gravid ovitrap (AGO) mosquito trap is an inexpensive, simple-to-assemble, and easy-to-maintain trap that targets female mosquitoes looking for a place to lay eggs. The current trap model stands 18 inches (45cm) tall and is made of a 5-gallon (18L) bucket. The AGO trap's unique design lures mosquitoes by using water and an all-natural, organic hay attractant. Once inside, female mosquitoes are captured on a nontoxic, sticky glue adhesive placed inside the capture chamber. The AGO trap has been successfully used by mosquito control programs for mosquito surveillance and control. Field trials in which the AGO trap has been installed in most homes in a community have shown it not only reduces mosquito populations but also rates of infection. This means that, in the community where AGO traps were installed, fewer people become sick from mosquito bites. Smaller scale field trials were so successful that CDC and the Puerto Rico Department of Health are implementing large-scale installation of AGO traps throughout several communities to help reduce mosquito populations and the viruses they spread.

Applications:
  • Trap can be used for surveillance and control of Aedes aegypti and Ae. albopictus mosquitoes known to spread Zika, dengue, yellow fever, chikungunya, and other viruses
  • Ae. aegypti and Ae. albopictus mosquitoes are found throughout tropical and subtropical countries throughout the world, including United States territories and the southern United States
Advantages:
  • Ovitraps attract female mosquitoes looking for a place to lay eggs
  • 100% nontoxic trap that does not use insecticide
  • Successfully field tested in communities and shown to reduce mosquito populations and the viruses they spread
  • Currently being used in Puerto Rico to help control the spread of Zika virus through mosquitoes

Patents

PCT Application PCT/US2012/025462
Filed on 2012-02-16
US Application 61/443,588
Filed on 2011-02-16
US Pat 10,219,505

Issued 2019-03-05
US Pat 9237741

Issued 2016-01-19

Foreign counterparts in Australia, Brazil, India, and Mexico

Publications

Acevedo V, et al.
PMID 27802402
Barrera R, et al.
24199506
Barrera R, et al.
PMID 24551969
Barrera R, et al.
PMID 25223937
Barrera, R. et al. 2010. “Field Trials of a New Gravid-ovitrap for Integrated Area-wide Control of Aedes Aegypti in Puerto Rico.” In Abstract Book, 83 (5 Supplement):179. The American Journal of Tropical Medicine and Hygiene. Atlanta, GA, USA.
http://www.astmh.org/ASTMH/media/Documents/AbstractBook3.pdf
Cornel AJ, et al.
PMID 27158450
Mackay AJ, et al.
PMID 23919568

Updated

Jul 23, 2019

Data Source: 
tts